Literature DB >> 2831335

Inhibition of superoxide anion production in guinea pig polymorphonuclear leukocytes by a seleno-organic compound, ebselen.

S Ichikawa1, K Omura, T Katayama, N Okamura, T Ohtsuka, S Ishibashi, H Masayasu.   

Abstract

Production of superoxide anion (O2-) induced by tetradecanoyl phorbol acetate (TPA) in intact guinea pig polymorphonuclear leukocytes (PMNL) was markedly inhibited by a seleno-organic compound, 2-phenyl-1,2-benzisoselenazol-3(2H)-one (Ebselen), with glutathione peroxidase-like activity. The compound almost completely inhibited O2- production by a particulate fraction prepared from TPA-treated PMNL at a concentration as low as 250 nM.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2831335     DOI: 10.1248/bpb1978.10.595

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  7 in total

Review 1.  The pharmacology of ebselen.

Authors:  M J Parnham; S Leyck; E Graf; E J Dowling; D R Blake
Journal:  Agents Actions       Date:  1991-01

Review 2.  Clinical trials for cytoprotection in stroke.

Authors:  Lise A Labiche; James C Grotta
Journal:  NeuroRx       Date:  2004-01

3.  Neuroprotective effects of ebselen on experimental spinal cord injury in rats.

Authors:  Murat Kalayci; Omer Coskun; Ferda Cagavi; Mehmet Kanter; Ferah Armutcu; Sanser Gul; Bektas Acikgoz
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

4.  Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen.

Authors:  S Leyck; M J Parnham
Journal:  Agents Actions       Date:  1990-06

5.  Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cells.

Authors:  Masanori Yoshizumi; Toshiaki Kogame; Yuki Suzaki; Yoshiko Fujita; Moe Kyaw; Kazuyoshi Kirima; Keisuke Ishizawa; Koichiro Tsuchiya; Shoji Kagami; Toshiaki Tamaki
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

6.  Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils.

Authors:  R A Patrick; P A Peters; A C Issekutz
Journal:  Agents Actions       Date:  1993-11

Review 7.  Toxicology and pharmacology of synthetic organoselenium compounds: an update.

Authors:  Cristina W Nogueira; Nilda V Barbosa; João B T Rocha
Journal:  Arch Toxicol       Date:  2021-04-01       Impact factor: 6.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.